Detection of Carbapenemase Producing Enterobacteriaceae using the Modified Carbapenem Inactivation Method | ||||
| Egyptian Journal of Medical Microbiology | ||||
| Volume 28, Issue 4, October 2019, Page 171-177 PDF (456.91 K) | ||||
| Document Type: New and original researches in the field of Microbiology. | ||||
| DOI: 10.21608/ejmm.2019.283501 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Maha M. Kotb  ; Hagar L. Mowafy
| ||||
| Department of Medical Microbiology and Immunology, Faculty of Medicine, Cairo University | ||||
| Abstract | ||||
| Background: Carbapenem resistant Enterobacteriaceae (CRE) have been reported worldwide. Resistance to carbapenems in Enterobacteriaceae is caused mainly by carbapenemase production or by porin loss combined with the expression of beta (β) -lactamases like extended-spectrum β-lactamases (ESBL) or ampicillin class C (AmpC). Objectives are to determine the prevalence of carbapenemase-producing Enterobacteriaceae (CPE) among 202 clinical isolates of Enterobacteriaceae by the phenotypic test the modified carbapenem inactivation method (mCIM). Methodology: Initial screening for carbapenemase-producing isolates among the 202 Enterobacteriaceae isolates was done by minimum inhibitory concentration (MIC) determination for ertapenem by broth microdilution method. Confirmation of carbapenemase production among ertapenem-resistant isolates was done by the phenotypic test mCIM. Results: The prevalence of CRE by broth microdilution method was 36.1% and the prevalence of CPE among resistant isolates was 80.8% by mCIM. Conclusion: The mCIM is inexpensive, easy to perform, requires no specific reagents or media. It could be performed to detect CPE in Enterobacteriaceae that are non-susceptible to one or more carbapenems. | ||||
| Keywords | ||||
| Carbapenemases producing Enterobacteriaceae; broth microdilution method; modified carbapenem inactivation method | ||||
|
Statistics Article View: 130 PDF Download: 87 |
||||
